| [1] |
LIU Hao, FU Miao, LIU Peng, TIAN Wen, WANG Sha, YIN Xiaomei, WANG Donghai.
Expressions and roles of WDR5 and miR-455-5p in cervical cancer patients
[J]. Laboratory Medicine, 2025, 40(9): 867-874.
|
| [2] |
LI Mingchao, SHEN Tong, ZHOU Binghe, DOU Xin, HU Liang, CHANG Dong, ZHANG Ze.
Evaluation of prognosis prediction effects in acute ischemic stroke patients based on machine learning algorithms
[J]. Laboratory Medicine, 2025, 40(10): 1004-1009.
|
| [3] |
WANG Hao, XIA Wenying, TONG Wei, WU Wenjia.
Level change and clinical significance of serum lipoprotein-associated phospholipase A2 in patients with depression
[J]. Laboratory Medicine, 2024, 39(9): 871-874.
|
| [4] |
CHEN Yongwei, WANG Jing, YANG Xiaolong, HU Fangyu, LIN Fang.
Applicability of CLSI EP09-A3 in 2-method comparison determining serum total triiodothyronine
[J]. Laboratory Medicine, 2024, 39(2): 176-180.
|
| [5] |
WANG Wei, ZHANG Zhixin, ZHANG Chuanbao, ZHOU Weiyan, WANG Zhiguo.
Establishment of allowable total error,allowable imprecision and allowable bias for 22 endocrine analytes
[J]. Laboratory Medicine, 2023, 38(8): 707-712.
|
| [6] |
TAN Chunyan, ZHOU Ying, MO Zhijiang.
Errors in Appendix B examples of WS/T 505—2017 and correction
[J]. Laboratory Medicine, 2023, 38(6): 569-573.
|
| [7] |
YANG Xiaodong, LI Quanle, PAN Qingqing, ZHOU Jing, XIE Yangmin, ZOU Jihua, SHEN Min, ZHANG Man.
Establishment and performance evaluation of candidate reference measurement procedure for the determination of immunosuppressive drugs in human whole blood by ID-LC-MS/MS
[J]. Laboratory Medicine, 2023, 38(3): 215-222.
|
| [8] |
HUANG Zhongqiang, DAI Di, HOU Tieying, LIN Faquan, LU Zhiming, LIU Xiaoqi, SHEN Minna, WU Jie, ZHANG Pingan, ZHOU Jun, XIAO Yanqun, WANG Hualiang.
Multicenter performance evaluation of a 7-microRNA test kit
[J]. Laboratory Medicine, 2023, 38(11): 1075-1081.
|
| [9] |
MIAO Yingbo, ZHAO Qiang, SONG Ying, ZHU Peichao, ZHOU Wei, XU Chong.
Research on performance specification of thrombelastogram
[J]. Laboratory Medicine, 2022, 37(7): 680-683.
|
| [10] |
ZHU Yuqing, WANG Haibin, WANG Lianming, ZHAO Fang, FENG Pinning, ZHANG Peng, GUO Shuren, PENG Yibing, CHENG Liming, CHUAN Liangmin, WANG Hualiang.
A multi-center evaluation of a domestic glutathione reductase determination kit
[J]. Laboratory Medicine, 2022, 37(5): 449-455.
|
| [11] |
LIU Congcong, LI Jiaping, ZHOU Hongwei.
Performance evaluation of 2 mass spectrometry systems in clinical microbial identification
[J]. Laboratory Medicine, 2022, 37(11): 1084-1088.
|
| [12] |
MAN Xianfeng, HE Xiaoting, ZHANG Ying, YU Weiwei, WANG Qi, YIN Hanwei, WANG Runjie.
Application of thioredoxin reductase in monitoring the curative effect of lung cancer
[J]. Laboratory Medicine, 2022, 37(1): 56-59.
|
| [13] |
TIAN Yueru, WANG Jingjing, AI Fuqi, MA Yimin, WANG Bei, JIANG Xiaofei.
Performance evaluation of Vitek 2 Compact AST-N334,AST-N335,AST-P639 Chinese antimicrobial susceptibility test cards
[J]. Laboratory Medicine, 2021, 36(4): 417-423.
|
| [14] |
Clinical Diagnosis and Laboratory Medicine Branch of China Maternal and Child Health Association.
Expert consensus on establishment of standards for the performance evaluation of systems for whole blood C-reactive protein determination of Chinese children
[J]. Laboratory Medicine, 2021, 36(12): 1201-1205.
|
| [15] |
TANG Chengfang, WEI Qingxiu, QIN Jianrong, TANG Fang, LIU Sichi, JIANG Xiang, HUANG Yonglan.
Comparison of different-brand tandem mass spectrometers for newborn screening of genetic metabolic diseases
[J]. Laboratory Medicine, 2021, 36(10): 1042-1046.
|